iPSC-RPE
/ Beijing Tongren Hospital
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 06, 2022
Safety and Efficacy of Autologous Transplantation of iPSC-RPE in the Treatment of Macular Degeneration
(clinicaltrials.gov)
- P1 | N=10 | Recruiting | Sponsor: Beijing Tongren Hospital
New P1 trial • Age-related Macular Degeneration • Macular Degeneration • Ophthalmology • Retinal Disorders • Transplantation • Wet Age-related Macular Degeneration
1 to 1
Of
1
Go to page
1